Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

On August 30, 2019 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September (Press release, Sangamo Therapeutics, AUG 30, 2019, View Source [SID1234539148]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2019 Healthcare Conference
Presentation Date: Thursday, Sept 5th at 10:55 a.m. Eastern Time
Location: Boston, MA
Morgan Stanley 17th Annual Global Healthcare Conference
Presentation Date: Monday, Sept 9th at 8:10 a.m. Eastern Time
Location: New York, NY
Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.